Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Institute Paoli-Calmettes
Marsella, FranciaPublicaciones en colaboración con investigadores/as de Institute Paoli-Calmettes (4)
2024
-
Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Journal of Clinical Oncology
-
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 12, pp. 1350-1356
2023
-
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Annals of Oncology, Vol. 34, Núm. 5, pp. 468-476
2017
-
Clinical outcomes of 217 patients with acute erythroleukemia according to treatment type and line: A retrospective multinational study
International Journal of Molecular Sciences, Vol. 18, Núm. 4